[go: up one dir, main page]

FI20155779A - Ei-steroidaalisen anti-inflammatorisen lääkkeen hidastetusti vapautuva annostelu - Google Patents

Ei-steroidaalisen anti-inflammatorisen lääkkeen hidastetusti vapautuva annostelu

Info

Publication number
FI20155779A
FI20155779A FI20155779A FI20155779A FI20155779A FI 20155779 A FI20155779 A FI 20155779A FI 20155779 A FI20155779 A FI 20155779A FI 20155779 A FI20155779 A FI 20155779A FI 20155779 A FI20155779 A FI 20155779A
Authority
FI
Finland
Prior art keywords
dosage
steroidal anti
delayed release
inflammatory drug
inflammatory
Prior art date
Application number
FI20155779A
Other languages
English (en)
Swedish (sv)
Other versions
FI20155779A7 (fi
Inventor
Elina Niskanen
Jaana Karjalainen
Jouko Uusitalo
Original Assignee
Solani Therapeutics Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Solani Therapeutics Ltd filed Critical Solani Therapeutics Ltd
Priority to FI20155779A priority Critical patent/FI20155779A7/fi
Priority to CA3042345A priority patent/CA3042345C/en
Priority to AU2016345552A priority patent/AU2016345552B2/en
Priority to ES16816319T priority patent/ES2757299T3/es
Priority to DK16816319T priority patent/DK3368015T3/da
Priority to PCT/FI2016/050759 priority patent/WO2017072415A1/en
Priority to US15/772,097 priority patent/US10548843B2/en
Priority to EP16816319.4A priority patent/EP3368015B1/en
Priority to JP2018541566A priority patent/JP2018536704A/ja
Priority to NZ742382A priority patent/NZ742382B2/en
Priority to PL16816319T priority patent/PL3368015T3/pl
Publication of FI20155779A publication Critical patent/FI20155779A/fi
Publication of FI20155779A7 publication Critical patent/FI20155779A7/fi

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1611Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/5415Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with carbocyclic ring systems, e.g. phenothiazine, chlorpromazine, piroxicam
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02Inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/02Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D279/00Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms
    • C07D279/021,2-Thiazines; Hydrogenated 1,2-thiazines
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08GMACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
    • C08G77/00Macromolecular compounds obtained by reactions forming a linkage containing silicon with or without sulfur, nitrogen, oxygen or carbon in the main chain of the macromolecule
    • C08G77/02Polysilicates
    • CCHEMISTRY; METALLURGY
    • C08ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08LCOMPOSITIONS OF MACROMOLECULAR COMPOUNDS
    • C08L83/00Compositions of macromolecular compounds obtained by reactions forming in the main chain of the macromolecule a linkage containing silicon with or without sulfur, nitrogen, oxygen or carbon only; Compositions of derivatives of such polymers
    • C08L83/02Polysilicates

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Rheumatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Pain & Pain Management (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
FI20155779A 2015-10-30 2015-10-30 Ei-steroidaalisen anti-inflammatorisen lääkkeen hidastetusti vapautuva annostelu FI20155779A7 (fi)

Priority Applications (11)

Application Number Priority Date Filing Date Title
FI20155779A FI20155779A7 (fi) 2015-10-30 2015-10-30 Ei-steroidaalisen anti-inflammatorisen lääkkeen hidastetusti vapautuva annostelu
CA3042345A CA3042345C (en) 2015-10-30 2016-10-31 Sustained-release non-steroidal anti-inflammatory drug delivery
AU2016345552A AU2016345552B2 (en) 2015-10-30 2016-10-31 Sustained-release non-steroidal anti-inflammatory drug delivery
ES16816319T ES2757299T3 (es) 2015-10-30 2016-10-31 Suministro de fármaco anti-inflamatorio no esteroideo de liberación sostenida
DK16816319T DK3368015T3 (da) 2015-10-30 2016-10-31 Levering af ikke-steroidt anti-inflammatorisk lægemiddel med vedvarende frigivelse
PCT/FI2016/050759 WO2017072415A1 (en) 2015-10-30 2016-10-31 Sustained-release non-steroidal anti-inflammatory drug delivery
US15/772,097 US10548843B2 (en) 2015-10-30 2016-10-31 Sustained-release silica composite depot non-steroidal anti-inflammatory drug delivery
EP16816319.4A EP3368015B1 (en) 2015-10-30 2016-10-31 Sustained-release non-steroidal anti-inflammatory drug delivery
JP2018541566A JP2018536704A (ja) 2015-10-30 2016-10-31 徐放性非ステロイド性抗炎症性薬物送達
NZ742382A NZ742382B2 (en) 2016-10-31 Sustained-release non-steroidal anti-inflammatory drug delivery
PL16816319T PL3368015T3 (pl) 2015-10-30 2016-10-31 Dostarczanie niesteroidowego leku przeciwzapalnego o przedłużonym uwalnianiu

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FI20155779A FI20155779A7 (fi) 2015-10-30 2015-10-30 Ei-steroidaalisen anti-inflammatorisen lääkkeen hidastetusti vapautuva annostelu

Publications (2)

Publication Number Publication Date
FI20155779A true FI20155779A (fi) 2017-05-01
FI20155779A7 FI20155779A7 (fi) 2017-05-01

Family

ID=57590534

Family Applications (1)

Application Number Title Priority Date Filing Date
FI20155779A FI20155779A7 (fi) 2015-10-30 2015-10-30 Ei-steroidaalisen anti-inflammatorisen lääkkeen hidastetusti vapautuva annostelu

Country Status (10)

Country Link
US (1) US10548843B2 (fi)
EP (1) EP3368015B1 (fi)
JP (1) JP2018536704A (fi)
AU (1) AU2016345552B2 (fi)
CA (1) CA3042345C (fi)
DK (1) DK3368015T3 (fi)
ES (1) ES2757299T3 (fi)
FI (1) FI20155779A7 (fi)
PL (1) PL3368015T3 (fi)
WO (1) WO2017072415A1 (fi)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019050749A1 (en) * 2017-09-08 2019-03-14 Eli Lilly And Company PHARMACEUTICAL COMBINATIONS COMPRISING INSULIN AND AT LEAST ONE AGENT SELECTED AMONG MELOXICAM, BROMFENAC SODIUM, ACETYLSALICYLIC ACID, SALICYLIC ACID AND PARACETAMOL
JP2023532778A (ja) * 2020-07-07 2023-07-31 デルシテック オサケユイチア シリカハイドロゲルコンポジットおよびその使用
US20220105029A1 (en) * 2020-10-07 2022-04-07 The Board Of Trustees Of The University Of Arkansas Biodegradable chitosan microneedle patch for transdermal delivery for livestock pain management

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1251650B (it) 1991-10-29 1995-05-17 Boehringer Ingelheim Italia Composti in incusione di meloxicam con ciclodestrine
WO1999009988A1 (en) 1997-08-27 1999-03-04 Hexal Ag New pharmaceutical compositions of meloxicam with improved solubility and bioavailability
NZ513013A (en) 1999-02-22 2002-11-26 Bioxid Oy Biodegradable ceramic fibres from silica sols useful in delivery devices for biologically active agents
AUPR602401A0 (en) * 2001-06-29 2001-07-26 Smart Drug Systems Inc Sustained release delivery system
WO2008051537A2 (en) 2006-10-20 2008-05-02 Coin Acceptors, Inc. A method of examining a coin for determining its validity and denomination
FI20070174A0 (fi) 2007-02-28 2007-02-28 Delsitech Oy Menetelmä silikakoostumusten valmistamiseksi, silikakoostumukset ja niiden käytöt
DE102008033327A1 (de) * 2008-07-16 2010-01-21 Bayer Innovation Gmbh Kieselsol-Material mit mindestens einem therapeutisch aktiven Wirkstoff zur Herstellung von biologisch degradierbaren und/oder resorbierbaren Kieselgel-Materialien für die Humanmedizin und/oder Medizintechnik
JP5316610B2 (ja) * 2011-08-03 2013-10-16 ダイキン工業株式会社 電気機器の制御装置および制御システム
US9533050B2 (en) 2011-12-29 2017-01-03 Laboratorios Andromaco S.A. Vaginal ring including meloxicam and an agent for modulating the release of the active principle, which can be used as a continuous-use contraceptive in women
US9250674B2 (en) * 2013-01-18 2016-02-02 General Electric Company Methods and systems for restoring power based on forecasted loads
HRP20200134T1 (hr) 2013-06-24 2020-08-21 Delsitech Oy Silika hidrogel kompozit
US9362773B2 (en) * 2013-06-28 2016-06-07 Nokia Technologies Oy Method and apparatus for determination of a non-charging operation
DK3134068T3 (da) * 2014-04-21 2021-10-04 Heron Therapeutics Inc Langtidsvirkende polymerafgivelsessystemer

Also Published As

Publication number Publication date
EP3368015A1 (en) 2018-09-05
PL3368015T3 (pl) 2020-02-28
AU2016345552B2 (en) 2022-04-14
CA3042345C (en) 2024-02-06
US20180311165A1 (en) 2018-11-01
NZ742382A (en) 2024-07-26
US10548843B2 (en) 2020-02-04
WO2017072415A1 (en) 2017-05-04
ES2757299T3 (es) 2020-04-28
DK3368015T3 (da) 2019-11-25
EP3368015B1 (en) 2019-08-28
JP2018536704A (ja) 2018-12-13
FI20155779A7 (fi) 2017-05-01
CA3042345A1 (en) 2017-05-04
AU2016345552A1 (en) 2018-06-21

Similar Documents

Publication Publication Date Title
NL301322I2 (nl) Repotrectinib en/of farmaceutisch aanvaardbare zouten daarvan
NL301217I2 (nl) tirzepatide en farmaceutisch aanvaardbare zouten daarvan
HUE047477T2 (hu) Palbociclib szilárd dózisformái
DK3244948T3 (da) Bestemmelse af medikamentdosis
DK3278803T3 (da) Fast farmaceutisk doseringsform af PARP-inhibitor, og anvendelse af fast farmaceutisk doseringsform af PARP-inhibitor
DK3383363T3 (da) Topiske farmaceutiske formuleringer til behandling af inflammatorisk-relaterede tilstande
DK3169328T3 (da) Quinolinderivater til behandling af inflammationssygdomme
DK3521282T3 (da) Quinazolinderivater anvendt til behandling af hiv
DK3157508T3 (da) Fast oral doseringsform af lipofile forbindelser
DK3212230T3 (da) Dosering og indgivelse af ikke-fucosylerede anti-CD40-antistoffer
DK3068392T5 (da) Fremgangsmåde til fremstilling af farmaceutiske sammensætninger til behandlingen af cftr-medierede sygdomme
DK3237045T3 (da) Indretning til indgivelse af lægemidler
DK3116491T3 (da) Farmaceutiske sammensætninger af terapeutisk aktive forbindelser
DK3102213T3 (da) Farmaceutiske sammensætninger til behandlingen af inflammatoriske lidelser
DK4335517T3 (da) Indgivelse og dosering af diaminofenothiaziner
DK3204398T3 (da) Fremgangsmåder til fraseparering af gemcitabin-phosphat diastereoisomerer
DK3324948T3 (da) Flerlagsmikropartikler til frigivelse af en farmaceutisk aktiv forbindelse i en flydende doseringsform
LT3212237T (lt) Metotreksato vaistinė forma
DK3185867T3 (da) Krystalliseringsfremgangsmåde af aripiprazolderivater i forlængede frigivelsesformuleringer til behandling af skizofreni
HRP20181572T1 (hr) Režim doziranja spoja fgf-18
DK3275452T3 (da) Farmaceutisk sammensætning med silibinin
IL258852A (en) Sustained release formulations of local anesthetics
DK3145497T3 (da) Coatede kapsler med modificeret frigivelse
DK3297619T3 (da) Terapeutiske anvendelser af L-4-chlorkynurenin
DK3145499T3 (da) Coatede kapsler med modificeret frigivelse

Legal Events

Date Code Title Description
FD Application lapsed